Pharma programmatic strategy, written down
Guides on healthcare programmatic media, written from five years of planning and buying pharma HCP and DTC campaigns. Guides are revised when platforms, rules, or benchmarks change. Search, filter by topic, or start with the case studies and foundational guides below. How these guides are written.
- 01Pharma marketing fundamentals
- 02HCP targeting and engagement
- 03DTC and patient marketing
- 04Compliance and privacy
- 05Measurement and Rx attribution
- 06CTV and video
- 07Programmatic buying and media quality
Showing all 90 articles
No articles match that search. Try a broader term, or clear the filter.
Pharma marketing fundamentals
How pharma commercial teams plan, position, and market a brand across its lifecycle.
Pharmaceutical Marketing Strategies: A Framework for Brand Teams
A practical framework for pharmaceutical marketing strategies, from market definition and audiences to positioning, channel mix, compliance, and measurement.
11 min read → Pharma Marketing BasicsTarget Marketing in Pharma: Segmentation, Targeting, and Positioning
Target marketing in pharma explained through segmentation, targeting, and positioning, with a hypothetical drug brand example for HCP and patient audiences.
6 min read → Pharma Marketing BasicsPharmaceutical Ads: Formats, Required Elements, and What Makes Them Work
Which risk elements each pharmaceutical ad format needs (brief summary, major statement, ISI) across product claim, reminder, and help-seeking ads.
6 min read → Pharma Marketing BasicsPharma Commercial Models: How Field, Digital, and Media Teams Fit Together
How the pharma commercial model works across rep-led, hybrid, digital-first, and key account approaches, and how media team roles change in each pharma model.
6 min read → HCP BasicsWhat Is HCP Marketing? Definition, Channels, and Examples
HCP marketing defined: how drug and device companies reach healthcare professionals, the main channels, how it is measured, and how it differs from B2B.
4 min read → HCP BasicsHCP vs. HCO: Targeting Providers and Healthcare Organizations
The difference between an HCP and an HCO, why organized care shifts influence from individual prescribers to systems, and how to plan media for both.
4 min read → HCP BasicsThe HCP Journey: Stages From First Awareness to Advocacy
The HCP journey explained: the stages a prescriber moves through with a new therapy, what each stage needs, and which channels and signals fit each one.
4 min read → HCP BasicsHCP Email Marketing: Lists, Permission, and Programmatic Links
How HCP email marketing works in pharma: owned vs rented lists, what to measure, and how email coordinates with programmatic media.
4 min read → Brand PlanningDrug Market Positioning: How Brands Choose Where to Compete
How drug brands choose a market position: patient, line of therapy, comparator, and benefit, with common positioning patterns and their risks.
3 min read → Brand PlanningPharmaceutical Market Segmentation: Bases, Methods, and Pitfalls
How pharmaceutical market segmentation works: bases for HCPs, patients, and payers, common methods, how to validate segments, and how to use them.
3 min read → Brand PlanningMarketing Strategy for a Phase 3 Drug: What to Do Before Approval
What marketing teams can and cannot do while a drug is in phase 3: research, disease education, list building, measurement setup, and launch readiness.
3 min read → Brand PlanningLoss of Exclusivity (LOE): Marketing and Media Scenario Planning
How brands plan marketing around loss of exclusivity: timing scenarios, erosion assumptions, what to cut first, what to protect, and measurement.
3 min read → GuideHow Pharma Commercial and Brand Teams Are Organized
How pharma commercial organizations are structured: brand teams, omnichannel, media, access, sales, analytics, and where agencies plug in.
3 min read → Pharma Marketing BasicsHCP vs. DTC Marketing: How the Two Tracks Differ and Work Together
HCP vs DTC marketing compared on audience, rules, channels, data, measurement, and budget, plus how to tell when a drug brand needs both tracks.
6 min read → Pharmaceutical marketing strategy fundamentalsPharmaceutical Campaign Planning: A Step-by-Step Process
A ten step pharmaceutical campaign planning process from objective and audience to MLR review, launch, optimization, and readout, with a working timeline table.
6 min read → Pharma brand planning, positioning, and lifecycleMarket Access Pull-Through Marketing: Targeting After a Formulary Win
What market access pull-through means, how brands turn formulary wins into prescriptions, how to target HCPs by plan coverage, and how to measure it.
4 min read →HCP targeting and engagement
Building HCP audiences from NPI lists, reaching them, and judging engagement.
HCP Audience Strategy: From NPI List to Meaningful Engagement
The full HCP audience decision chain in pharma media, from target-list governance and targeting unit to sequencing, engagement signals, and Rx measurement.
3 min read → HCP TargetingHow to Sequence HCP Media Across Display, Video, and Professional Channels
A state-based approach to sequencing HCP media, giving each channel a clear job and an observable signal instead of a rigid funnel.
3 min read → HCP TargetingHow to Measure HCP Target-List Reach Without Hiding Denominator Problems
A three-denominator standard for reporting HCP target-list reach so partners cannot inflate coverage by choosing a convenient universe.
3 min read → GuideHCP Engagement: What It Means and How Pharma Teams Build It
HCP engagement means a prescriber has moved through observable states, from reached to acting. Here is how pharma teams define, build, and measure it.
10 min read → HCP EngagementHow to Measure ROI on HCP Marketing Spend
How do you measure ROI on HCP marketing spend? Use incremental Rx, net revenue per script, margin, and full cost. A worked hypothetical example shows the math.
6 min read → NPI & HCP ProgrammaticWhat Is HCP Targeting? A Plain-Language Explainer
What is HCP targeting? A plain explanation of who counts as an HCP, why marketing to them differs from consumer marketing, and the main targeting methods.
6 min read → NPI & HCP ProgrammaticHCP Programmatic Advertising: Channels, Inventory, and Buying Paths
HCP programmatic advertising runs across endemic sites, open web, PMPs, CTV, and social. What each channel is for and how to choose a buying path for pharma.
5 min read → Precision MedicineHow HCP Data Products Are Priced: Tiers, Licenses, and Usage Fees
How pricing tiers for HCP targeting data products compare: annual licenses, per-CPM usage, per-NPI fees, and project pricing, with a hypothetical example.
6 min read → HCP EngagementMeasuring HCP Sentiment: Surveys, Field Feedback, and Media Signals
Four ways to measure HCP sentiment (ATU surveys, field feedback, content engagement, social listening), what each misses, and how to combine them.
6 min read → Point of CareHow Point-of-Care Media Is Priced: Guarantees, Reach, and Sponsorships
How point-of-care media is priced for pharma: guaranteed HCP impressions, reach guarantees, sponsorships, screen networks, and fair cost comparison.
4 min read → Point of CareWaiting-Room Media: Programmatic vs. Location-Direct Buys
Waiting-room and exam-room media for pharma: programmatic vs location-direct buys, how to compare costs, and how to measure patient impact.
4 min read → Point of CareHIPAA-Safe Reporting When Point-of-Care Exposure Is Matched to Pharmacy Fills
How point-of-care exposure can be matched to pharmacy fills without exposing PHI: de-identification, aggregation, roles, and vendor questions.
4 min read → NPI targeting and HCP programmatic advertising1:1 HCP Targeting: How It Works and Where It Breaks
1:1 HCP targeting promises ads served to specific NPIs. Here is how deterministic claims are built, what verified means, and how to test a 1:1 claim yourself.
6 min read → Point-of-care and EHR media for pharmaEHR Advertising for Pharma: How Messages Reach Prescribers in the Workflow
How EHR advertising works for pharma: programmatic EHR targeting by NPI, placements and triggers, content rules, buying paths, and fit with a media plan.
6 min read → NPI targeting and HCP programmatic advertisingNPI Marketing Beyond Display: Email, Field, Point of Care, and Social
NPI marketing reaches more than display. Compare email, field, point of care, social, and CTV channels on how each matches to NPIs and what it can measure.
5 min read → HCP marketing fundamentals, definedHCP Opt-In Collection: Building a Permissioned Physician Audience
How pharma collects HCP opt-ins for email and digital programs, what valid permission looks like, and how to grow and maintain a permissioned audience.
4 min read → Point-of-care and EHR media for pharmaPoint-of-Care Marketing in Pharma: Channels, Buying, and Measurement
How point-of-care marketing works for pharma: EHR messaging, waiting and exam room media, clinical apps, buying, pricing, rules, and measurement.
3 min read → Pharma teams, agencies, and data partnersQuestions to Ask an HCP Advertising Agency Before You Hire
Questions to ask an HCP advertising agency before hiring: experience, HCP data, channels, review, measurement, transparency, team, and fees.
4 min read → NPI targeting and HCP programmatic advertisingHCP Identity Matching: How an NPI Becomes an Addressable Audience
HCP identity matching turns an NPI list into reachable devices and logins. How emails, site logins, device graphs, and hashed IDs work, and why rates differ.
6 min read → Healthcare programmatic beyond pharma brandsHow to Use Contextual Advertising to Reach HCPs
How contextual advertising can reach HCPs: clinical content signals, endemic contexts, verification, pairing with NPI targeting, and measurement.
3 min read →DTC and patient marketing
Reaching patients and caregivers, and the platforms that support the patient journey.
What Is DTC in Healthcare? Pharma, Devices, Telehealth, and Direct-to-Patient
What is DTC in healthcare? A plain guide to direct-to-consumer pharma, devices, telehealth, and direct-to-patient programs, and how the rules differ.
6 min read → GuideHow to Evaluate Direct-to-Patient Healthcare and Pharmacy Platforms
A six-part checklist for evaluating direct-to-patient pharmacy and telehealth platforms, from clinical quality to privacy, with a simple scoring sheet.
4 min read → DTC MarketingDirect-to-Patient Pharma Programs and What They Change for Media
How direct-to-patient pharma programs change DTC media, measurement, and compliance, plus evaluation factors for DTP healthcare and pharmacy platforms.
5 min read → DTC MarketingCondition and Ailment Audience Targeting: How It Works and Where the Privacy Lines Are
How ailment audience targeting works for DTC healthcare audiences, where condition data comes from, and the NAI, state law, and consent limits.
6 min read →Compliance and privacy
FDA promotion rules, privacy law, and transparency reporting as they apply to media teams.
Pharma Marketing Compliance: A Working Guide for Media Teams
A working guide to pharma marketing compliance for media teams: who regulates what, what the media team owns, and a checklist by campaign stage.
10 min read → Compliance & PrivacyFair Balance in Digital Pharma Ads: Banners, Video, and Social
What fair balance means in digital pharma ads under 21 CFR 202.1, how ISI works in banners, video, and social, and the format mistakes that cause problems.
8 min read → Compliance & PrivacyOPDP Untitled and Warning Letters: What Media Teams Can Learn
What OPDP untitled letters and warning letters are, the themes that recur, how media format and placement contribute, and how to read the letters on FDA's site.
6 min read → Compliance & PrivacyReminder Ads, Help-Seeking Ads, and Product Claim Ads Explained
Reminder ads, help seeking ads, and product claim ads explained: what each FDA ad type can say, when risk information is required, and how media can mix them.
7 min read → Compliance OpsOpen Payments vs. Aggregate Spend Reporting: What Differs
How Open Payments differs from aggregate spend reporting: what each covers, who reports, state laws, and what marketing and media teams need to track.
3 min read → Compliance & PrivacyWhat Compliance Capabilities to Require From a Pharma Media Agency
What compliance and specialist capabilities a pharma brand should require from its media agency: a checklist for MLR, ISI, adverse events, and privacy.
6 min read → Compliance & PrivacyThe FTC Health Breach Notification Rule: What Health Marketers Need to Know
The FTC Health Breach Notification Rule explained for marketers: who it covers after the 2024 update, why pixel sharing can be a breach, and what to check.
7 min read → Compliance & PrivacyMLR Review for Programmatic Media: How to Get Faster Approvals
How MLR review works for programmatic media: what reviewers check in creative, targeting, and landing pages, what to submit, and how to speed approvals.
6 min read → Compliance & PrivacyHIPAA and Pharma Advertising: Where It Applies and Where It Does Not
HIPAA and pharma advertising explained: why manufacturers are usually not covered entities, when HIPAA reaches marketing data, and what tracking guidance means.
7 min read → Pharma compliance operations and global rulesPharma Advertising in Europe: Why DTC Rules Differ From the US
How EU pharma advertising rules differ from the US: no public promotion of Rx medicines, disease awareness, HCP promotion, codes, and GDPR.
3 min read → Pharma compliance operations and global rulesMLR Review Tools and Workflow: What Speeds Approval
What MLR review and approval software does, what to compare when choosing it, and the workflow habits, modular content, and metrics that speed approval.
5 min read →Measurement and Rx attribution
Rx attribution, holdouts, marketing mix models, and the analytics stack behind them.
How to Interpret Reach, Frequency, and Duplication Together
A four-scenario matrix for reading reach, frequency, and duplication together in pharma media reports, to avoid optimizing a single metric.
3 min read → Measurement PlatformsWhat Is Crossix? How Veeva Crossix Measurement Works
What is Crossix? A plain explanation of Veeva Crossix, how its privacy-safe health data supports audiences and Crossix measurement, and what to ask.
7 min read → Measurement PlatformsWhat Is a Holdout Test? A Plain-Language Guide for Marketers
What is a holdout test? A plain explanation of how marketers withhold ads from a random group, size the test, read the result, and avoid the common mistakes.
6 min read → Measurement PlatformsMarketing Mix Modeling for Pharma: When It Beats Rx Attribution
How marketing mix modeling works for pharma, the data it needs, where it beats Rx attribution for TV and cross channel planning, and how to pair it with tests.
6 min read → GuidePharma Marketing Analytics Stack: Which Tool Answers Which Question
A map of pharma analytics tools by the question each answers: delivery, reach, engagement, Rx attribution, incrementality, MMM, and research.
3 min read → Measurement PlatformsPoint-of-Care Campaign Measurement: Pixels, Conversions, and Physician Engagement
How point of care campaign measurement works, what tracking pixels and conversion events can capture in EHR and clinical apps, and why there is no typical ROI.
7 min read → Series guidePharma Outcomes Measurement Platforms: How to Choose and Use Them
A practical guide to pharma outcomes measurement platforms, from Crossix measurement to claims, EHR, and lab data, and how to judge HCP media performance.
10 min read → Analytics ToolsWhat Is Script Lift? Pharma Prescription Lift Explained
Script lift explained: what prescription lift means in pharma, how it is calculated, absolute vs relative lift, NRx vs TRx, and how to judge a lift claim.
4 min read → Point-of-care and EHR media for pharmaHow Pharma Measures the ROI of EHR Advertising
How to measure EHR advertising ROI: Rx lift studies, control groups, what counts as cost and return, common biases, and credible reporting.
3 min read → HCP marketing fundamentals, definedHow to Measure HCP Advocacy Without Overreading Signals
What HCP advocacy means, the signals brands use to measure it, which ones hold up, and how to build an advocacy measure that does not overstate influence.
3 min read → Pharma analytics tools and test designHCP Surveys and Market Research: Methods, Panels, and Pitfalls
How pharma uses HCP surveys and market research for insights, which methods fit which questions, how panels work, and how to avoid biased or unusable results.
3 min read →CTV and video
Buying, planning, and measuring connected TV and online video for healthcare brands.
How to Measure Deduplicated Reach Across CTV and Online Video
How to report cross-channel video reach honestly by separating observed, modeled, and unavailable duplication between CTV and online video.
3 min read → CTV MeasurementLinear TV vs. CTV for Pharma DTC: How to Decide the Shift
Linear TV vs. CTV for pharma DTC brands: how audience age, cost, targeting, measurement, and fair balance length should shape the shift in budget.
6 min read → CTV MeasurementPharma CTV Creative: Length, Fair Balance, and Interactive Formats
A guide to pharma CTV creative: choosing 15, 30, or 60 second spots with a major statement, using QR codes, pause ads, and interactive units under MLR review.
7 min read → CTV BuyingEffective Frequency on Connected TV: How to Set and Measure It
What effective frequency means on connected TV, how to set a frequency range for health campaigns, how to measure it across apps, and when to adjust.
3 min read → CTV BuyingCTV SSP Fees and Take Rates: Public Benchmarks and How to Compare Supply Partners
What CTV SSPs take: public fee benchmarks, why rates vary by deal type, and how to compare supply partners on the share of spend that reaches publishers.
3 min read → CTV MeasurementMeasuring Reach and Frequency Across Linear TV, CTV, and Online Video
How advertisers can measure reach and frequency across linear TV, CTV, and online video, with cross-platform currencies, dedup methods, and a pharma approach.
7 min read → CTV MeasurementHow CTV Measurement Providers Differ on Reach, Frequency, and Device Deduplication
How panels, ACR, census server data, and identity graphs count CTV reach, frequency, and device deduplication differently, and what to ask each provider.
7 min read → CTV BuyingAd Deduplication vs. Frequency Capping: What Is the Difference?
The difference between ad deduplication and frequency capping, why caps fail across CTV apps and partners, and how deduplicated measurement fixes the picture.
4 min read → CTV BuyingCTV Distribution Deals: Smart TV, Operator, and App Platforms in One Buy
How CTV distribution works across smart TVs, devices, and operators, why one show is sold by several parties, and how to buy across them cleanly.
4 min read → CTV BuyingHow to Evaluate a CTV Syndication Partner
What CTV syndication partners do and what to ask before buying: sources, authorization, unique reach, frequency control, fees, and measurement.
4 min read → CTV buying, distribution, and frequency explainedCTV Device Graphs Explained: Linking TVs, Phones, and Households
What a CTV device graph is, how it links TVs to other devices and households, how accuracy is tested, and how it affects measurement.
3 min read → Healthcare CTV, OTT, and TV measurementTools for Measuring CTV Incrementality: Methods and Tradeoffs
The main tools for measuring CTV incrementality, including ghost ads, holdouts, geo tests, matched panels, and MMM, and what each one needs to work.
7 min read → Healthcare CTV, OTT, and TV measurementCTV for HCPs: Can Streaming TV Reach Physicians?
How CTV for HCPs works: matching NPI lists to households, realistic scale, spillover to family members, which messages fit, and how to measure it.
7 min read → CTV buying, distribution, and frequency explainedHow CTV Reach Is Measured Without Cookies
How CTV reach is measured without cookies: IP addresses, device IDs, ACR, panels, and identity graphs, and why providers report different reach.
4 min read →Programmatic buying and media quality
Supply paths, fees, identity data, and what separates quality media from cheap media.
Working Media vs. Nonworking Costs in Pharma Programmatic
Classify pharma programmatic media, data, technology, measurement, creative, and agency costs without mistaking a higher working-media ratio for value.
3 min read → Healthcare ProgrammaticEndemic vs. Non-Endemic Media for Pharma
Endemic vs non-endemic media for pharma: medical publishers, EHR, and point of care compared with open web, CTV, and social on cost, reach, and context.
5 min read → Media Quality ExplainedWhat Is Non-Working Media? Definitions and Examples
Non-working media is spend that does not buy ad space: creative, fees, ad tech, data. Examples, a worked working media ratio, and why it is not waste.
6 min read → Media Quality ExplainedQuality Path Optimization (QPO): The IAS Approach and Doing It In-House
What quality path optimization (QPO) means, how the IAS Total Visibility version works, how it differs from SPO, and how to run it in-house as a buyer.
5 min read → GuideWhat Is an Identity Graph? A Healthcare Marketer's Guide
What an identity graph is, how it links people, devices, and households, deterministic vs probabilistic links, and its uses and limits in health.
3 min read → GuideHealthcare Programmatic by Advertiser Type: Pharma, Devices, Providers, Payers, and More
How healthcare programmatic differs by advertiser: pharma, devices, diagnostics, providers, health plans, public health, OTC, and digital health.
3 min read → Media Quality ExplainedPacing in Programmatic: Overpacing, Underpacing, and Even Delivery Explained
What overpacing means, what causes over and underpacing, ASAP vs even pacing, and how to read a pacing index before you change bids or budgets.
6 min read → Media Quality ExplainedHow to Evaluate a Third-Party Business Identity Graph Before You Use It
Best practices for evaluating accuracy of third-party business identity graphs before marketing automation: truth sets, recency, coverage, pilots.
6 min read → Media Quality ExplainedViewability, Attention, and Invalid Traffic: The Three Quality Checks
How viewability, attention, and invalid traffic work as quality checks for pharma: the MRC viewability standard, GIVT vs SIVT, and attention limits.
6 min read → Identity & DataCan Clean Rooms Measure Partner Overlap? Yes, With Caveats
How data clean rooms measure audience overlap between partners, what results mean, common pitfalls, and how health brands should set them up.
4 min read → Guide · DSP evaluation, inventory quality, PMPs, and supply pathsHow to Evaluate a DSP for Pharmaceutical Advertising
A requirements-to-evidence process for choosing a demand-side platform for pharma, covering health data, controls, supply, measurement, and fees.
3 min read → Healthcare programmatic advertisingPharma Contextual Advertising: How to Build Contextual Segments That Work
How to build pharma contextual advertising segments: keyword vs semantic targeting, adjacent content, negative contexts, and testing against audiences.
6 min read → Healthcare programmatic advertisingProgrammatic Advertising in Healthcare: How It Works for Pharma, Providers, and Payers
How programmatic advertising in healthcare works for pharma, devices, hospitals, payers, and telehealth, and what makes healthcare programmatic media different.
10 min read → Healthcare programmatic advertisingHealthcare Programmatic Targeting Options Compared
Healthcare programmatic targeting options compared: NPI, condition audiences, contextual, endemic, geographic, first-party, lookalike, and retargeting.
6 min read → DSP evaluation, inventory quality, PMPs, and supply pathsQuestions to Ask in a Healthcare DSP Demo
What to expect in a healthcare DSP demo, what to prepare first, and seven scenario questions that make the vendor show live evidence, not slides.
5 min read →Interactive tools
Free, no signup. Both are stripped-down versions of things I use on real pharma portfolios.
Pharma DSP Picker
Three questions, one directional platform recommendation for an HCP or DTC campaign, built on the criteria that actually decide it.
Open the tool → Tool · Campaign ManagementPortfolio Pacing Dashboard
Pacing, eCPM efficiency, and anomaly flags across a sample 10-brand portfolio, with the written diagnosis behind every flag.
Open the demo →Campaign case studies
Five campaigns I planned, activated, or measured, written up with the result and the limits of the measurement behind it. If you are hiring and want to see how I think, start here.
Taking an HCP Buy Off the Open Exchange
Completion rate climbed from 51.95% to 59.97% and held every day, with a portfolio Rx efficiency read alongside it.
Read case study → Case Study · Audience DataFive Percent of the Budget, Half the Incremental Refills
One integrated rare disease outcomes study, several partners, and the smallest investment producing the only significant refill lift.
Read case study → Case Study · Media EfficiencyCutting HCP Data Costs 70% Without Losing Engagement
Testing the precision premium on oncology audience data, and what happened to engagement when the savings moved into media.
Read case study → Case Study · Audience DataRetail Purchase Signal at 1/9th the Cost of Rx Claims
Ten data partners, one month, one measurement platform. Inmar retail signal reached verified patients at $2.88 vs an $11.71 blend.
Read case study → Case Study · AttributionDecoding Rx Attribution with Crossix and IQVIA
A challenge-approach-results case study, including a 31.5% visit-to-Rx conversion on a compressed seasonal launch.
Read case study →Foundational guides
The original long-form guides on the site: fundamentals, HCP targeting, measurement, CTV, compliance, and DSP selection.
The Ultimate Guide to Pharma Programmatic Advertising
A full primer on healthcare programmatic fundamentals, RTB mechanics, and where the channel is heading.
Read guide → Role GuideThe Role of a Pharma Programmatic Strategist
A hiring-focused view of responsibilities, competencies, and cross-functional leadership value.
Read role guide → Strategic PlaybookMastering HCP Targeting Best Practices
Designing NPI-informed audience strategy, contextual placements, and a weekly optimization cadence.
Read playbook → Identity & DataCookieless HCP Targeting
Why deterministic NPI targeting survives signal loss, where match graphs are fragile, and the identity stack to build now.
Read analysis → Measurement FrameworkHow Programmatic Media Drives Rx Outcomes
Crossix, IQVIA, target-list reach, conversion lift, and the measurement architecture behind Rx attribution.
Read framework → Planning ReferencePharma Programmatic Benchmarks
The directional CPM, match rate, reach, and visit-to-Rx planning numbers I actually use, with honest caveats.
See benchmarks → Measurement · Publisher DataWhat "Publisher Has Not Implemented Quantcast Measurement" Means
Why a site shows estimated instead of measured audience data, and what a buyer should ask for when direct measurement is missing.
Read article → Channel StrategyPharma CTV Advertising: The Streaming Playbook
NPI-matched HCP streaming, DTC contextual buys, fair balance in video, inventory quality, and Rx measurement.
Read playbook → DTC StrategyDTC Programmatic Activation in Pharma
Channel mix, compliance-aware targeting, and outcomes measurement that goes beyond clicks.
Read article → Category Deep DiveGLP-1 DTC Advertising Strategy
What pharma's loudest category teaches media teams about demand, competition, compliance, and measurement.
Read deep dive → DSP ComparisonDeepIntent vs IQVIA vs PulsePoint for Pharma
Healthcare targeting, compliance, measurement, and pharma-specific DSP capabilities compared side by side.
Compare DSPs →Hiring for a pharma programmatic role? See the case studies, try the live planning tool, or grab the résumé.